首页> 外文会议>Annual Meeting of the Japanese Association for Animal Cell Technology >Anti-histone HI Autoantibody: An Inducible Immunosuppressive Factor in Liver Transplantation
【24h】

Anti-histone HI Autoantibody: An Inducible Immunosuppressive Factor in Liver Transplantation

机译:抗组成蛋白质HI自身抗体:肝移植中的诱导免疫抑制因子

获取原文

摘要

In a rat model of tolerogeneic liver transplantation, serum from the recipient has been shown to exhibit a strong immunosuppressive activity. However, molecular identity of those humoral factors has yet to be elucidated. We previously found that one of major immunosuppressive factors in the recipient serum was transplantation-induced IgG antibodies. Here we identified an antigen recognized by the regulatory IgG as histone HI. Polyclonal antibody raised against histone HI not only suppressed allogeneic mixed lymphocyte reaction (MLR), but also prolonged allograft survival in vivo. To elucidate mechanisms underlying the immunosuppressive activity, we generated murine anti-histone HI monoclonal antibodies (mAbs) which can suppress allogeneic MLR. One of selected mAbs, termed 16G9, showed a dose-dependent MLR inhibitory activity. Flow cytometric analysis revealed that 16G9 specifically reacted with a part of murine splenocytes including T cells, B cells, and CD1 lb~+ monocytes/macrophages. These results raise a possibility that 16G9 may suppress MLR via cross-reaction with target antigens on the leukocytes.
机译:在耐受性肝移植的大鼠模型中,已显示来自接受者的血清表现出强烈的免疫抑制活性。然而,这些体液因素的分子标识尚未阐明。我们以前发现受体血清中主要免疫抑制因子中的一种是移植诱导的IgG抗体。在这里,我们鉴定了调节IgG作为组蛋白HI识别的抗原。多克隆抗体施加抗组蛋白HI,不仅抑制了同种异体混合淋巴细胞反应(MLR),还延长了体内同种异体移植物存活。为了阐明免疫抑制活性的潜在机制,我们产生了可以抑制同种异体MLR的鼠抗组蛋白HI单克隆抗体(MAb)。被称为16G9的选定的MAb中的一种表现出剂量依赖性的MLR抑制活性。流式细胞术分析显示16G9与包括T细胞,B细胞和CD11b〜+单核细胞/巨噬细胞的一部分小鼠脾细胞特异性反应。这些结果提高了16G9可以通过与白细胞上的靶抗原的交叉反应来抑制MLR的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号